Binay Kumar Shah Selected Research

Imatinib Mesylate (Gleevec)

4/2016	Racial Differences in Survival of Elderly Adults with Chronic Myeloid Leukemia Before and After the Introduction of Imatinib in the United States.
12/2014	Second primary malignancies in chronic myeloid leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Binay Kumar Shah Research Topics

Disease

3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 04/2016 - 12/2014
3	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 04/2015 - 09/2014
2	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2016 - 06/2015
2	Neoplasms (Cancer) 07/2015 - 12/2014
1	Glioblastoma (Glioblastoma Multiforme) 01/2016
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2015
1	Blindness (Hysterical Blindness) 11/2014
1	Heart Failure 10/2014
1	Anaphylaxis (Anaphylactic Shock) 05/2013
1	Prostatic Neoplasms (Prostate Cancer) 01/2013
1	Iron-Deficiency Anemia (Anemia, Iron Deficiency) 01/2011
1	Thrombocytopenia (Thrombopenia) 01/2011
1	Anemia 02/2002

Drug/Important Bio-Agent (IBA)

2	Imatinib Mesylate (Gleevec)FDA Link 04/2016 - 12/2014
2	Tyrosine Kinase InhibitorsIBA 01/2015 - 12/2014
2	IronIBA 01/2011 - 02/2002
1	Temozolomide (Temodar)FDA LinkGeneric 01/2016
1	Sorafenib (BAY 43-9006)FDA Link 01/2015
1	Vincristine (Oncovin)FDA LinkGeneric 11/2014
1	Bortezomib (Velcade)FDA Link 10/2014
1	Rituximab (Mabthera)FDA Link 09/2014
1	Pemetrexed (MTA)FDA Link 05/2013
1	abirateroneIBA 01/2013
1	Folic Acid (Vitamin M)FDA LinkGeneric 02/2002

Therapy/Procedure

5	Radiotherapy 01/2016 - 04/2015
2	Therapeutics 01/2016 - 02/2002
1	Drug Therapy (Chemotherapy) 11/2014
1	Castration 01/2013
1	Erythrocyte Transfusion 01/2011